Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2187495rdf:typepubmed:Citationlld:pubmed
pubmed-article:2187495lifeskim:mentionsumls-concept:C0080096lld:lifeskim
pubmed-article:2187495lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:2187495pubmed:issue2-3lld:pubmed
pubmed-article:2187495pubmed:dateCreated1990-6-25lld:pubmed
pubmed-article:2187495pubmed:abstractTextInterleukin-3 (IL-3) regulates the proliferation of myeloid, erythroid, and lymphoid cells. Previous reports showed IL-3 binding restricted to a single high-affinity (Kd = 50-200 pM) site. Here, we demonstrate by equilibrium studies an additional binding site for IL-3 with lower apparent affinity (Kd = 5-20 nM). Furthermore, kinetic analysis shows that two binding sites for IL-3 exist: IL-3 dissociates slowly from the first site (T1/2 = 4 hr; k-1 = 2.7 x 10(-3) min-1), whereas it dissociates rapidly (T1/2 = 4.0 min; k-1 = 0.116 min-1) from the second site. Cross-linking showed that [125I]IL-3 binding to the 115- and 140-kD proteins was not saturable at concentrations commensurate with high-affinity binding and IL-3 dissociated rapidly from these same molecules. Thus, the low affinity IL-3 receptor is a molecule(s) of 115- to 140-kD.lld:pubmed
pubmed-article:2187495pubmed:languageenglld:pubmed
pubmed-article:2187495pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2187495pubmed:citationSubsetIMlld:pubmed
pubmed-article:2187495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2187495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2187495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2187495pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2187495pubmed:statusMEDLINElld:pubmed
pubmed-article:2187495pubmed:issn0897-7194lld:pubmed
pubmed-article:2187495pubmed:authorpubmed-author:AraiKKlld:pubmed
pubmed-article:2187495pubmed:authorpubmed-author:MiyajimaAAlld:pubmed
pubmed-article:2187495pubmed:authorpubmed-author:SchreursJJlld:pubmed
pubmed-article:2187495pubmed:issnTypePrintlld:pubmed
pubmed-article:2187495pubmed:volume2lld:pubmed
pubmed-article:2187495pubmed:ownerNLMlld:pubmed
pubmed-article:2187495pubmed:authorsCompleteYlld:pubmed
pubmed-article:2187495pubmed:pagination221-33lld:pubmed
pubmed-article:2187495pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:meshHeadingpubmed-meshheading:2187495-...lld:pubmed
pubmed-article:2187495pubmed:year1990lld:pubmed
pubmed-article:2187495pubmed:articleTitleEvidence for a low-affinity interleukin-3 receptor.lld:pubmed
pubmed-article:2187495pubmed:affiliationDepartment of Molecular Biology, DNAX Research Institute of Molecular and Cellular Biology, Palo Alto, CA 94304-1104.lld:pubmed
pubmed-article:2187495pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2187495lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2187495lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2187495lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2187495lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2187495lld:pubmed